Boj s aterosklerózou u žen.
Stále hledáme lepší načasování

Czech version

Authors: Jan Piťha
Authors‘ workplace: Interní klinika 2. LF UK a FN v Motole, Praha
Published in: Prakt Gyn 2016; 20(2): 77-80
Category: Gynecology and Obstetrics

Overview

Women are affected by clinical events of atherosclerotic origin with the same frequency as men. These events are only postponed into older age in women. On the one hand, large observational studies did not indicate the presence of specific cardiovascular factors in women. On the other hand, unique feature for preventing atherosclerosis in the female population may be more effective timing of management of cardiovascular factors in a particular period of woman life. This particular period could be menopausal transition and/or time interval immediately after menopause (approximately 6 years).

Key words:
atherosclerosis – timing of management – menopausal transition – women

Sources

1. Kannel WB, Schatzkin A. Sudden death: lessons from subsets in population studies. J Am Coll Cardiol 1985; 5(6 Suppl): 141B-149B.

2. Zdravotnická ročenka České republiky. Dostupné z WWW: <http://www.uzis.cz/katalog/rocenky/zdravotnicka-rocenka-ceske-republiky>.

3. Willeit J, Kiechl S, Oberhollenzer F et al. Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. Arterioscler Thromb Vasc Biol 2000; 20(2): 529–537.

4. Kiechl S, Willeit J. The natural course of atherosclerosis. Part II: vascular remodeling. Bruneck Study Group. Arterioscler Thromb Vasc Biol 1999; 19(6): 1491–1498.

5. Kiechl S, Willeit J. The natural course of atherosclerosis. Part I: incidence and progression. Arterioscler Thromb Vasc Biol 1999; 19(6):1484–1490.

6. Grundtvig M, Hagen TP, German M et al. Sex-based differences in premature first myocardial infarction caused by smoking: twice as many years lost by women as by men. Eur J Cardiovasc Prev Rehabil 2009; 16(2): 174–179.

7. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 2011; 378(9799): 1297–1305.

8. Peters SA, Huxley RR, Woodward M. Smoking as a Risk Factor for Stroke in Women Compared With Men: A Systematic Review and Meta-Analysis of 81 Cohorts, Including 3 980 359 Individuals and 42 401 Strokes. Stroke 2013; 44(10): 2821–2828.

9. Barrett-Connor E, Cohn BA, Wingard DL et al. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? JAMA 1991; 2658ř9: 627–631. Erratum in JAMA 1991; 265(24): 3249.

10. van der Meer MG, van der Graaf Y, Schuit E et al. Added Value of Female-Specific Factors Beyond Traditional Predictors for Future Cardiovascular Disease. J Am Coll Cardiol 2016; 67(17): 2084–2086.

11. Rossouw JE, Anderson GL, Prentice RL et al. [Writing Group for the Women’s Health Initiative Investigators]. Risks and benefits of estrogen plus progestin in healthy postmenopausal women:principal results From the Women’s Health Initiative randomized controlled trial. JAMA 2002; 288(3): 321–333.

12. Heiss G, Wallace R, Anderson GL et al. [WHI Investigators]. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 2008; 299(9): 1036–1045.

13. Clarkson TB. Can women be identified that will derive considerable cardiovascular benefits from postmenopausal estrogen therapy? J Clin Endocrinol Metab 2008; 93(1): 37–39.

14. Clarkson TB. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause 2007; 14(3 Pt 1): 373–384.

15. Rosolová H. Do statins and hormonal replacement therapy in combination reduce cardiovascular risk in postmenopausal women? Eur Heart J 2000; 21(3): 178–180.

16. Hodis HN, Mack WJ, Henderson VW et al. [ELITE Research Group]. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. N Engl J Med 2016; 374(13): 1221–1231.

17. Santoro N, Sutton-Tyrrell K. The SWAN song: Study of Women’s Health Across the Nation’s recurring themes. Obstet Gynecol Clin North Am 2011; 38(3): 417–423.

18. Pappa T, Alevizaki M. Endogenous sex steroids and cardio- and cerebro-vascular disease in the postmenopausal period. Eur J Endocrinol 2012; 167(2): 145–156.

19. Pitha J, Králová Lesná I, Sekerková A et al. Menopausal transition enhances the atherogenic risk of smoking in middle aged women. Int J Cardiol 2013; 168(1): 190–196.

20. Pitha J, Auzký O, Kovář J et al. Changes in cardiovascular risk profile in women after menopause (Prague Pre and Post Menopausal Female study). Cor et Vasa 2014; 56: e113 – e117. Dostupné z DOI: <http://dx.doi.org/10.1016/j.crvasa.2014.01.004>.